Vijay Aggarwal - 01 Feb 2022 Form 4 Insider Report for INTERPACE BIOSCIENCES, INC. (IDXG)

Reporting relationship: Director
Issuer ticker: IDXG
Reported as of: 01 Feb 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Feb 2022, 15:03:40 UTC
Source filing: View source filing
Reporting owner signature: /s/ Vijay Aggarwal

Key filing fact

Vijay Aggarwal filed Form 4 for INTERPACE BIOSCIENCES, INC. (IDXG) on 02 Feb 2022.

Key facts

This page summarizes Vijay Aggarwal's Form 4 filing for INTERPACE BIOSCIENCES, INC. (IDXG).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Feb 2022, 15:03.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IDXG transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +28,000
Change %
Price: $0.000000
Shares after: 28,000
Date: 01 Feb 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 28,000
Exercise price: $5.04
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options will vest in three equal annual installments beginning on February 1, 2023, subject to the Reporting Person's continued service on each such vesting date.